Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TRH binds to a membrane receptor that activates several intracellular signaling pathways and increases transcription of the
TSH
and prolactin (PRL) genes. Although TRH induces
TSH
and PRL gene expression, the underlying mechanism is not clear. In this report we examined the role of the Ca(2+)/calmodulin-dependent protein (CaM) kinase cascade in mediating TRH-stimulated transcription of
TSH
and PRL. RT-PCR and Western blot analysis were used to show that
CaM kinase
kinase (CaM-KK) and CaM IV (CaM-KIV) were present in rat anterior pituitary and its cell line GH(3). Next, the effects of constitutively active CaM-KIV (CaM-KIVc) or its dominant negative mutant (CaM-KIVdn) on
TSH
and PRL promoter activity were tested in GH(3) cells. The results showed that either CaM-KIVc alone or an upstream kinase, CaM-KK, induced the activity of both
TSH
and PRL promoters. Exposure of GH(3) cells to 100 microm TRH induced CaM-KIV activity within 5 min and, as expected, also increased both
TSH
and PRL promoter activity. In contrast, cells carrying the CaM-KIVdn isoform had suppressed TRH induction of both
TSH
and PRL promoter activity. These results indicate that the CaM-KK-CaM-KIV cascade probably plays an important role in TRH induction of
TSH
and PRL transcriptional activity in pituitary cells.
...
PMID:Role of calcium-calmodulin-dependent protein kinase cascade in thyrotropin (TSH)-releasing hormone induction of TSH and prolactin gene expression. 1530 8